MeSH Browser

MeSH Heading: Calcifediol
Tree Number(s): D04.210.500.247.222.159.478.250; D04.210.500.247.808.146.478.250; D04.210.500.812.768.196.478.250; D10.570.938.146.478.250
Unique ID: D002112
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/D002112
Annotation: deficiency: coordinate CALCIFEDIOL /‌defic (IM) with VITAMIN D DEFICIENCY (IM)
Scope Note: The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
Entry Term(s): 25-Hydroxycholecalciferol; 25-Hydroxycholecalciferol Monohydrate; 25-Hydroxyvitamin D 3; 25-Hydroxyvitamin D3; Calcidiol; Calcifediol Anhydrous; Calcifediol, (3 alpha,5Z,7E)-Isomer; Calcifediol, (3 beta,5E,7E)-Isomer; Calderol; Dedrogyl; Hidroferol
Pharm Action: Vitamins
Bone Density Conservation Agents
Registry Number: P6YZ13C99Q
Related Numbers: 19356-17-3; 36149-00-5; 73809-05-9; T0WXW8F54E
CAS Type 1 Name: 9,10-Secocholesta-5,7,10(19)-triene-3,25-diol, (3beta,5Z,7E)-
Previous Indexing: Cholecalciferols (1966-1972); Hydroxycholecalciferols (1972-1982)
Public MeSH Note: 83
History Note: 83
Date Established: 1983/01/01
Date of Entry: 1982/05/04
Revision Date: 2017/05/24

Allowable Qualifiers: administration & dosage (AD)

adverse effects (AE)

agonists (AG)

analogs & derivatives (AA)

analysis (AN)

antagonists & inhibitors (AI)

biosynthesis (BI)

blood (BL)

cerebrospinal fluid (CF)

chemical synthesis (CS)

chemistry (CH)

classification (CL)

deficiency (DF)

economics (EC)

genetics (GE)

history (HI)

immunology (IM)

isolation & purification (IP)

metabolism (ME)

pharmacokinetics (PK)

pharmacology (PD)

physiology (PH)

poisoning (PO)

radiation effects (RE)

standards (ST)

supply & distribution (SD)

therapeutic use (TU)

toxicity (TO)

urine (UR)

Concept UI: M0003141
Registry Number: P6YZ13C99Q
Related Numbers: 19356-17-3; 36149-00-5; 73809-05-9; T0WXW8F54E
Scope Note: The major circulating metabolite of VITAMIN D3. It is produced in the LIVER and is the best indicator of the body's vitamin D stores. It is effective in the treatment of RICKETS and OSTEOMALACIA, both in azotemic and non-azotemic patients. Calcifediol also has mineralizing properties.
Terms: Calcifediol Preferred Term
Term UI T005990
Date01/01/1999
LexicalTag NON
ThesaurusID; 25-Hydroxyvitamin D 3
Term UI T005989
Date05/04/1982
LexicalTag NON
ThesaurusID UNK (19XX); 25-Hydroxycholecalciferol Monohydrate
Term UI T845780
Date06/17/2013
LexicalTag NON
ThesaurusID NLM (2014); 25-Hydroxyvitamin D3
Term UI T005993
Date04/04/1989
LexicalTag NON
ThesaurusID NLM (1990); Calcidiol
Term UI T005994
Date01/16/1996
LexicalTag NON
ThesaurusID NLM (1997); 25-Hydroxycholecalciferol
Term UI T005988
Date05/04/1982
LexicalTag NON
ThesaurusID UNK (19XX)

Calcifediol MeSH Descriptor Data 2024